Healthy subjects (including MCI) who are aware of the decline in cognitive function due to aging
Conditions
Interventions
Oral intake of the test foods (3 chewable in a day for 12 weeks)
Oral intake of the placebo foods (3 chewable in a day for 12 weeks)
Sponsors
Kanyukai clinic
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Healthy subjects with MMSE results by screening test of 24 points or more(healthy person who feels deterioration of cognitive function due to aging and person with mild cognitive impairment) 2) Healthy adults aged 40 to 75 years old. 3) Gender: No preference 4) Subjects without smoking habits 5) Subjects who do not have a habit of taking a meal containing test foods (dairy products such as milk, yogurt, and cheese) 6)Subjects who do not regularly use supplements and health foods (including lactic acid bacteria and bifidobacteria) 7) Subjects who do not suffer from lifestyle diseases (high blood pressure, diabetes etc.), rheumatism, liver disorders, renal disorders, other chronic diseases 8) Subjects who have no history of treatment of malignant tumor, heart failure, myocardial infarction 9) Subjects who have no history of allergy to test foods / medicines 10) Subjects who do not take medication for Outpatient treatment 11)Subjects who are judged by the investigator to have no problem in conducting the trial based on the results of blood tests. 12) Subjects giving written informed consent
Exclusion criteria
Exclusion criteria: 1) Females who are pregnant or lactating, and females who could become pregnant or lactating during test period 2) Subjects who are participating the other clinical tests. Subjects who participated within 3-month prior to the current study 3) Subjects who do not comply with instructions from the doctor or medical staff 4) Others who have been determined ineligible by investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of cognitive function by Cognitrax test at 0 week and at 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of bowel movements by Defecation survey form at 0 week and at 12 weeks | — |
Countries
Japan
Contacts
Public ContactTaisuke Fukaya
Tashikani Plus Co., Ltd CEO
Outcome results
None listed